| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Mar 18, 2025 | Anika Therapeutics, Inc. | CEO | Sell | 42.5 | -12,152 | -5.49% | ✗ | $193.3K |
| Mar 11, 2025 | Mar 13, 2025 | Anika Therapeutics, Inc. | CEO | Sell | 42.5 | -12,675 | -6.07% | ✗ | $212.8K |
| Mar 10, 2025 | Mar 11, 2025 | Anika Therapeutics, Inc. | CEO | Sell | 42.5 | -5,871 | -3.18% | ✗ | $97.6K |
| Mar 11, 2024 | Mar 12, 2024 | Anika Therapeutics, Inc. | CEO | Sell | 40.0 | -27,980 | -6.21% | ✗ | $716.6K |
| Apr 26, 2023 | Apr 28, 2023 | Anika Therapeutics, Inc. | CEO | Sell | 40.0 | -10,900 | -7.96% | ✗ | $287.1K |
| Mar 10, 2023 | Mar 14, 2023 | Anika Therapeutics, Inc. | CEO | Sell | 40.0 | -13,211 | -10.52% | ✗ | $344.8K |
| Mar 9, 2023 | Mar 10, 2023 | Anika Therapeutics, Inc. | CEO | Sell | 42.5 | -4,232 | -4.24% | ✗ | $113.9K |
| Mar 11, 2022 | Mar 14, 2022 | Anika Therapeutics, Inc. | CEO | Buy | 95.0 | +8,100 | 15.61% | ✗ | $207.1K |
| Apr 26, 2020 | Apr 28, 2020 | Anika Therapeutics, Inc. | CEO | Sell | 42.5 | -1,794 | -15.34% | ✗ | $59.9K |